 | • レポートコード：QY2108PAL8562 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、166ページ • 納品方法：Eメール（納期：1日） • 産業分類：医療装置 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける動物用ワクチンの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、動物用ワクチンの種類別市場規模（弱毒生ワクチン、不活化ワクチン、その他）、用途別市場規模（家畜、豚、鶏、犬・猫、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の動物用ワクチン市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における動物用ワクチンの種類別市場規模（2016年-2027年）：弱毒生ワクチン、不活化ワクチン、その他 ・世界における動物用ワクチンの用途別市場規模（2016年-2027年）：家畜、豚、鶏、犬・猫、その他 ・動物用ワクチンの中国市場分析 - 動物用ワクチンの中国市場規模（2016年-2027年） - 中国における動物用ワクチンの主要プレイヤー別市場シェア - 中国における動物用ワクチンの種類別市場規模：弱毒生ワクチン、不活化ワクチン、その他 - 中国における動物用ワクチンの用途別市場規模：家畜、豚、鶏、犬・猫、その他 ・動物用ワクチンの北米市場（2016年-2027年） ・動物用ワクチンのヨーロッパ市場（2016年-2027年） ・動物用ワクチンのアジア太平洋市場（2016年-2027年） ・動物用ワクチンの中南米市場（2016年-2027年） ・動物用ワクチンの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Merck、Zoetis、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco、Virbac、Jinyu Bio-Technology、ChengDu Tecbond、CAVAC、Kyoto Biken Laboratories、FATRO、Vaksindo、Bio-Labs、Avimex Animal Health、MEVAC、Biovac、Atafen、Dyntec、BioTestLab、RVSRI、Medion ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.
Market Analysis and Insights: Global and China Veterinary Vaccine Market
This report focuses on global and China Veterinary Vaccine market.
In 2020, the global Veterinary Vaccine market size was US$ 7784 million and it is expected to reach US$ 11850 million by the end of 2027, with a CAGR of 6.1% during 2021-2027. In China the Veterinary Vaccine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Veterinary Vaccine Scope and Market Size
Veterinary Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Veterinary Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Others
Segment by Application
Livestock
Swine
Chicken
Dog & Cat
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Greece
Ukraine
Moldova
Albania
Serbia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Egypt
South Africa
Israel
Kuwait
Iran
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
BioTestLab
RVSRI
Medion
1 Study Coverage
1.1 Veterinary Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Veterinary Vaccine Market Size Growth Rate by Type
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccine Market Size Growth Rate by Application
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Dog & Cat
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Veterinary Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Veterinary Vaccine Revenue 2016-2027
2.1.2 Global Veterinary Vaccine Sales 2016-2027
2.2 Global Veterinary Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Veterinary Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Veterinary Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Veterinary Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Veterinary Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Veterinary Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Veterinary Vaccine Revenue Forecast by Region (2022-2027)
3 Global Veterinary Vaccine Competitor Landscape by Players
3.1 Global Top Veterinary Vaccine Manufacturers by Sales
3.1.1 Global Veterinary Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Veterinary Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Veterinary Vaccine Manufacturers by Revenue
3.2.1 Key Veterinary Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Veterinary Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Veterinary Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Veterinary Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Veterinary Vaccine Revenue in 2020
3.2.6 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Veterinary Vaccine Price by Manufacturers
3.4 Global Veterinary Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Veterinary Vaccine Market Size by Type (2016-2021)
4.1.1 Global Veterinary Vaccine Sales by Type (2016-2021)
4.1.2 Global Veterinary Vaccine Revenue by Type (2016-2021)
4.1.3 Veterinary Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Veterinary Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Veterinary Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Veterinary Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Veterinary Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Veterinary Vaccine Market Size by Application (2016-2021)
5.1.1 Global Veterinary Vaccine Sales by Application (2016-2021)
5.1.2 Global Veterinary Vaccine Revenue by Application (2016-2021)
5.1.3 Veterinary Vaccine Price by Application (2016-2021)
5.2 Veterinary Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Veterinary Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Veterinary Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Veterinary Vaccine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Veterinary Vaccine Market Size YoY Growth 2016-2027
6.1.1 China Veterinary Vaccine Sales YoY Growth 2016-2027
6.1.2 China Veterinary Vaccine Revenue YoY Growth 2016-2027
6.1.3 China Veterinary Vaccine Market Share in Global Market 2016-2027
6.2 China Veterinary Vaccine Market Size by Players (International and Local Players)
6.2.1 China Top Veterinary Vaccine Players by Sales (2016-2021)
6.2.2 China Top Veterinary Vaccine Players by Revenue (2016-2021)
6.3 China Veterinary Vaccine Historic Market Review by Type (2016-2021)
6.3.1 China Veterinary Vaccine Sales Market Share by Type (2016-2021)
6.3.2 China Veterinary Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 China Veterinary Vaccine Price by Type (2016-2021)
6.4 China Veterinary Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Veterinary Vaccine Sales Forecast by Type (2022-2027)
6.4.2 China Veterinary Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 China Veterinary Vaccine Price Forecast by Type (2022-2027)
6.5 China Veterinary Vaccine Historic Market Review by Application (2016-2021)
6.5.1 China Veterinary Vaccine Sales Market Share by Application (2016-2021)
6.5.2 China Veterinary Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 China Veterinary Vaccine Price by Application (2016-2021)
6.6 China Veterinary Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Veterinary Vaccine Sales Forecast by Application (2022-2027)
6.6.2 China Veterinary Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 China Veterinary Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Veterinary Vaccine Market Size YoY Growth 2016-2027
7.2 North America Veterinary Vaccine Market Facts & Figures by Country
7.2.1 North America Veterinary Vaccine Sales by Country (2016-2021)
7.2.2 North America Veterinary Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Veterinary Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Veterinary Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Veterinary Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Veterinary Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Veterinary Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Veterinary Vaccine Market Facts & Figures by Country
9.2.1 Europe Veterinary Vaccine Sales by Country (2016-2021)
9.2.2 Europe Veterinary Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
9.2.7 Greece
9.2.8 Greece
9.2.9 Ukraine
9.2.10 Moldova
9.2.11 Albania
9.2.12 Serbia
10 Latin America
10.1 Latin America Veterinary Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Veterinary Vaccine Market Facts & Figures by Country
10.2.1 Latin America Veterinary Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Veterinary Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Veterinary Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Veterinary Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Veterinary Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Veterinary Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
11.2.6 Egypt
11.2.7 South Africa
11.2.8 Israel
11.2.9 Kuwait
11.2.10 Iran
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Veterinary Vaccine Products Offered
12.1.5 Merck Recent Development
12.2 Zoetis
12.2.1 Zoetis Corporation Information
12.2.2 Zoetis Description and Business Overview
12.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Zoetis Veterinary Vaccine Products Offered
12.2.5 Zoetis Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Veterinary Vaccine Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Ceva
12.4.1 Ceva Corporation Information
12.4.2 Ceva Description and Business Overview
12.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ceva Veterinary Vaccine Products Offered
12.4.5 Ceva Recent Development
12.5 CAHIC
12.5.1 CAHIC Corporation Information
12.5.2 CAHIC Description and Business Overview
12.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CAHIC Veterinary Vaccine Products Offered
12.5.5 CAHIC Recent Development
12.6 HVRI
12.6.1 HVRI Corporation Information
12.6.2 HVRI Description and Business Overview
12.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 HVRI Veterinary Vaccine Products Offered
12.6.5 HVRI Recent Development
12.7 Ringpu Biology
12.7.1 Ringpu Biology Corporation Information
12.7.2 Ringpu Biology Description and Business Overview
12.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ringpu Biology Veterinary Vaccine Products Offered
12.7.5 Ringpu Biology Recent Development
12.8 Yebio
12.8.1 Yebio Corporation Information
12.8.2 Yebio Description and Business Overview
12.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Yebio Veterinary Vaccine Products Offered
12.8.5 Yebio Recent Development
12.9 DHN
12.9.1 DHN Corporation Information
12.9.2 DHN Description and Business Overview
12.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 DHN Veterinary Vaccine Products Offered
12.9.5 DHN Recent Development
12.10 WINSUN
12.10.1 WINSUN Corporation Information
12.10.2 WINSUN Description and Business Overview
12.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 WINSUN Veterinary Vaccine Products Offered
12.10.5 WINSUN Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Veterinary Vaccine Products Offered
12.11.5 Merck Recent Development
12.12 Virbac
12.12.1 Virbac Corporation Information
12.12.2 Virbac Description and Business Overview
12.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Virbac Products Offered
12.12.5 Virbac Recent Development
12.13 Jinyu Bio-Technology
12.13.1 Jinyu Bio-Technology Corporation Information
12.13.2 Jinyu Bio-Technology Description and Business Overview
12.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jinyu Bio-Technology Products Offered
12.13.5 Jinyu Bio-Technology Recent Development
12.14 ChengDu Tecbond
12.14.1 ChengDu Tecbond Corporation Information
12.14.2 ChengDu Tecbond Description and Business Overview
12.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 ChengDu Tecbond Products Offered
12.14.5 ChengDu Tecbond Recent Development
12.15 CAVAC
12.15.1 CAVAC Corporation Information
12.15.2 CAVAC Description and Business Overview
12.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 CAVAC Products Offered
12.15.5 CAVAC Recent Development
12.16 Kyoto Biken Laboratories
12.16.1 Kyoto Biken Laboratories Corporation Information
12.16.2 Kyoto Biken Laboratories Description and Business Overview
12.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Kyoto Biken Laboratories Products Offered
12.16.5 Kyoto Biken Laboratories Recent Development
12.17 FATRO
12.17.1 FATRO Corporation Information
12.17.2 FATRO Description and Business Overview
12.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 FATRO Products Offered
12.17.5 FATRO Recent Development
12.18 Vaksindo
12.18.1 Vaksindo Corporation Information
12.18.2 Vaksindo Description and Business Overview
12.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Vaksindo Products Offered
12.18.5 Vaksindo Recent Development
12.19 Bio-Labs
12.19.1 Bio-Labs Corporation Information
12.19.2 Bio-Labs Description and Business Overview
12.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Bio-Labs Products Offered
12.19.5 Bio-Labs Recent Development
12.20 Avimex Animal Health
12.20.1 Avimex Animal Health Corporation Information
12.20.2 Avimex Animal Health Description and Business Overview
12.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Avimex Animal Health Products Offered
12.20.5 Avimex Animal Health Recent Development
12.21 MEVAC
12.21.1 MEVAC Corporation Information
12.21.2 MEVAC Description and Business Overview
12.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.21.4 MEVAC Products Offered
12.21.5 MEVAC Recent Development
12.22 Biovac
12.22.1 Biovac Corporation Information
12.22.2 Biovac Description and Business Overview
12.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Biovac Products Offered
12.22.5 Biovac Recent Development
12.23 Atafen
12.23.1 Atafen Corporation Information
12.23.2 Atafen Description and Business Overview
12.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Atafen Products Offered
12.23.5 Atafen Recent Development
12.24 Dyntec
12.24.1 Dyntec Corporation Information
12.24.2 Dyntec Description and Business Overview
12.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Dyntec Products Offered
12.24.5 Dyntec Recent Development
12.25 BioTestLab
12.25.1 BioTestLab Corporation Information
12.25.2 BioTestLab Description and Business Overview
12.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.25.4 BioTestLab Products Offered
12.25.5 BioTestLab Recent Development
12.26 RVSRI
12.26.1 RVSRI Corporation Information
12.26.2 RVSRI Description and Business Overview
12.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.26.4 RVSRI Products Offered
12.26.5 RVSRI Recent Development
12.27 Medion
12.27.1 Medion Corporation Information
12.27.2 Medion Description and Business Overview
12.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Medion Products Offered
12.27.5 Medion Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Veterinary Vaccine Industry Trends
13.2 Veterinary Vaccine Market Drivers
13.3 Veterinary Vaccine Market Challenges
13.4 Veterinary Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Veterinary Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Live Attenuated Vaccines
Table 3. Major Manufacturers of Inactivated Vaccines
Table 4. Major Manufacturers of Others
Table 5. Global Veterinary Vaccine Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 6. Global Veterinary Vaccine Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Veterinary Vaccine Sales by Regions (2016-2021) & (M Doses)
Table 8. Global Veterinary Vaccine Sales Market Share by Regions (2016-2021)
Table 9. Global Veterinary Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Veterinary Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
Table 11. Global Veterinary Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Veterinary Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Veterinary Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Veterinary Vaccine Sales by Manufacturers (2016-2021) (M Doses)
Table 15. Global Veterinary Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Veterinary Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Veterinary Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Veterinary Vaccine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Vaccine as of 2020)
Table 21. Key Manufacturers Veterinary Vaccine Price (2016-2021) (USD/Doses)
Table 22. Veterinary Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Veterinary Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Veterinary Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Veterinary Vaccine Sales by Type (2016-2021) (M Doses)
Table 27. Global Veterinary Vaccine Sales Share by Type (2016-2021)
Table 28. Global Veterinary Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Veterinary Vaccine Revenue Share by Type (2016-2021)
Table 30. Veterinary Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Doses)
Table 31. Global Veterinary Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
Table 32. Global Veterinary Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Veterinary Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Veterinary Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Veterinary Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Doses)
Table 36. Global Veterinary Vaccine Sales by Application (2016-2021) (M Doses)
Table 37. Global Veterinary Vaccine Sales Share by Application (2016-2021)
Table 38. Global Veterinary Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Veterinary Vaccine Revenue Share by Application (2016-2021)
Table 40. Veterinary Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Doses)
Table 41. Global Veterinary Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
Table 42. Global Veterinary Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Veterinary Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Veterinary Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Veterinary Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Doses)
Table 46. China Veterinary Vaccine Sales (M Doses) of Key Companies (2016-2021)
Table 47. China Veterinary Vaccine Sales Share by Company (2016-2021)
Table 48. China Veterinary Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 49. China Veterinary Vaccine Revenue Share by Company (2016-2021)
Table 50. China Veterinary Vaccine Sales (M Doses) by Type (2016-2021)
Table 51. China Veterinary Vaccine Sales Share by Type (2016-2021)
Table 52. China Veterinary Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Veterinary Vaccine Price (USD/Doses) by Type (2016-2021)
Table 54. China Veterinary Vaccine Sales (M Doses) by Type (2022-2027)
Table 55. China Veterinary Vaccine Sales Share by Type (2022-2027)
Table 56. China Veterinary Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Veterinary Vaccine Revenue Share by Type (2022-2027)
Table 58. China Veterinary Vaccine Price (USD/Doses) by Type (2022-2027)
Table 59. China Veterinary Vaccine Sales (M Doses) by Application (2016-2021)
Table 60. China Veterinary Vaccine Sales Share by Application (2016-2021)
Table 61. China Veterinary Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Veterinary Vaccine Price (USD/Doses) by Application (2016-2021)
Table 63. China Veterinary Vaccine Sales (M Doses) by Application (2022-2027)
Table 64. China Veterinary Vaccine Sales Share by Application (2022-2027)
Table 65. China Veterinary Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Veterinary Vaccine Revenue Share by Application (2022-2027)
Table 67. China Veterinary Vaccine Price (USD/Doses) by Application (2022-2027)
Table 68. North America Veterinary Vaccine Sales by Country (2016-2021) & (M Doses)
Table 69. North America Veterinary Vaccine Sales Market Share by Country (2016-2021)
Table 70. North America Veterinary Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Veterinary Vaccine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Veterinary Vaccine Sales by Region (2016-2021) & (M Doses)
Table 73. Asia Pacific Veterinary Vaccine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Veterinary Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Veterinary Vaccine Revenue Market Share by Region (2016-2021)
Table 76. Europe Veterinary Vaccine Sales by Country (2016-2021) & (M Doses)
Table 77. Europe Veterinary Vaccine Sales Market Share by Country (2016-2021)
Table 78. Europe Veterinary Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Veterinary Vaccine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Veterinary Vaccine Sales by Country (2016-2021) & (M Doses)
Table 81. Latin America Veterinary Vaccine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Veterinary Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Veterinary Vaccine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Veterinary Vaccine Sales by Country (2016-2021) & (M Doses)
Table 85. Middle East and Africa Veterinary Vaccine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Veterinary Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Veterinary Vaccine Revenue Market Share by Country (2016-2021)
Table 88. Merck Corporation Information
Table 89. Merck Description and Business Overview
Table 90. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 91. Merck Veterinary Vaccine Product
Table 92. Merck Recent Development
Table 93. Zoetis Corporation Information
Table 94. Zoetis Description and Business Overview
Table 95. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 96. Zoetis Product
Table 97. Zoetis Recent Development
Table 98. Boehringer Ingelheim Corporation Information
Table 99. Boehringer Ingelheim Description and Business Overview
Table 100. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 101. Boehringer Ingelheim Product
Table 102. Boehringer Ingelheim Recent Development
Table 103. Ceva Corporation Information
Table 104. Ceva Description and Business Overview
Table 105. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 106. Ceva Product
Table 107. Ceva Recent Development
Table 108. CAHIC Corporation Information
Table 109. CAHIC Description and Business Overview
Table 110. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 111. CAHIC Product
Table 112. CAHIC Recent Development
Table 113. HVRI Corporation Information
Table 114. HVRI Description and Business Overview
Table 115. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 116. HVRI Product
Table 117. HVRI Recent Development
Table 118. Ringpu Biology Corporation Information
Table 119. Ringpu Biology Description and Business Overview
Table 120. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 121. Ringpu Biology Product
Table 122. Ringpu Biology Recent Development
Table 123. Yebio Corporation Information
Table 124. Yebio Description and Business Overview
Table 125. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 126. Yebio Product
Table 127. Yebio Recent Development
Table 128. DHN Corporation Information
Table 129. DHN Description and Business Overview
Table 130. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 131. DHN Product
Table 132. DHN Recent Development
Table 133. WINSUN Corporation Information
Table 134. WINSUN Description and Business Overview
Table 135. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 136. WINSUN Product
Table 137. WINSUN Recent Development
Table 138. Elanco Corporation Information
Table 139. Elanco Description and Business Overview
Table 140. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 141. Elanco Product
Table 142. Elanco Recent Development
Table 143. Virbac Corporation Information
Table 144. Virbac Description and Business Overview
Table 145. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 146. Virbac Product
Table 147. Virbac Recent Development
Table 148. Jinyu Bio-Technology Corporation Information
Table 149. Jinyu Bio-Technology Description and Business Overview
Table 150. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 151. Jinyu Bio-Technology Product
Table 152. Jinyu Bio-Technology Recent Development
Table 153. ChengDu Tecbond Corporation Information
Table 154. ChengDu Tecbond Description and Business Overview
Table 155. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 156. ChengDu Tecbond Product
Table 157. ChengDu Tecbond Recent Development
Table 158. CAVAC Corporation Information
Table 159. CAVAC Description and Business Overview
Table 160. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 161. CAVAC Product
Table 162. CAVAC Recent Development
Table 163. Kyoto Biken Laboratories Corporation Information
Table 164. Kyoto Biken Laboratories Description and Business Overview
Table 165. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 166. Kyoto Biken Laboratories Product
Table 167. Kyoto Biken Laboratories Recent Development
Table 168. FATRO Corporation Information
Table 169. FATRO Description and Business Overview
Table 170. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 171. FATRO Product
Table 172. FATRO Recent Development
Table 173. Vaksindo Corporation Information
Table 174. Vaksindo Description and Business Overview
Table 175. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 176. Vaksindo Product
Table 177. Vaksindo Recent Development
Table 178. Bio-Labs Corporation Information
Table 179. Bio-Labs Description and Business Overview
Table 180. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 181. Bio-Labs Product
Table 182. Bio-Labs Recent Development
Table 183. Avimex Animal Health Corporation Information
Table 184. Avimex Animal Health Description and Business Overview
Table 185. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 186. Avimex Animal Health Product
Table 187. Avimex Animal Health Recent Development
Table 188. MEVAC Corporation Information
Table 189. MEVAC Description and Business Overview
Table 190. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 191. MEVAC Product
Table 192. MEVAC Recent Development
Table 193. Biovac Corporation Information
Table 194. Biovac Description and Business Overview
Table 195. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 196. Biovac Product
Table 197. Biovac Recent Development
Table 198. Atafen Corporation Information
Table 199. Atafen Description and Business Overview
Table 200. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 201. Atafen Product
Table 202. Atafen Recent Development
Table 203. Dyntec Corporation Information
Table 204. Dyntec Description and Business Overview
Table 205. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 206. Dyntec Product
Table 207. Dyntec Recent Development
Table 208. BioTestLab Corporation Information
Table 209. BioTestLab Description and Business Overview
Table 210. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 211. BioTestLab Product
Table 212. BioTestLab Recent Development
Table 213. RVSRI Corporation Information
Table 214. RVSRI Description and Business Overview
Table 215. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 216. RVSRI Product
Table 217. RVSRI Recent Development
Table 218. Medion Corporation Information
Table 219. Medion Description and Business Overview
Table 220. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 221. Medion Product
Table 222. Medion Recent Development
Table 223. Veterinary Vaccine Market Trends
Table 224. Veterinary Vaccine Market Drivers
Table 225. Veterinary Vaccine Market Challenges
Table 226. Veterinary Vaccine Market Restraints
Table 227. Veterinary Vaccine Customers List
Table 228. Veterinary Vaccine Distributors List
Table 229. Research Programs/Design for This Report
Table 230. Key Data Information from Secondary Sources
Table 231. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Vaccine Product Picture
Figure 2. Global Veterinary Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Live Attenuated Vaccines Product Picture
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Others Product Picture
Figure 6. Global Veterinary Vaccine Sales Market Share by Application in 2020 & 2027
Figure 7. Livestock
Figure 8. Swine
Figure 9. Chicken
Figure 10. Dog & Cat
Figure 11. Others
Figure 12. Veterinary Vaccine Report Years Considered
Figure 13. Global Veterinary Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Veterinary Vaccine Market Size 2016-2027 (US$ Million)
Figure 15. Global Veterinary Vaccine Sales 2016-2027 (M Doses)
Figure 16. Global Veterinary Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Veterinary Vaccine Sales Market Share by Region (2016-2021)
Figure 18. Global Veterinary Vaccine Sales Market Share by Region in 2020
Figure 19. Global Veterinary Vaccine Revenue Market Share by Region (2016-2021)
Figure 20. Global Veterinary Vaccine Revenue Market Share by Region in 2020
Figure 21. Global Veterinary Vaccine Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Veterinary Vaccine Revenue in 2020
Figure 23. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Veterinary Vaccine Sales Market Share by Type (2016-2021)
Figure 25. Global Veterinary Vaccine Sales Market Share by Type in 2020
Figure 26. Global Veterinary Vaccine Revenue Market Share by Type (2016-2021)
Figure 27. Global Veterinary Vaccine Revenue Market Share by Type in 2020
Figure 28. Global Veterinary Vaccine Sales Market Share by Application (2016-2021)
Figure 29. Global Veterinary Vaccine Sales Market Share by Application in 2020
Figure 30. Global Veterinary Vaccine Revenue Market Share by Application (2016-2021)
Figure 31. Global Veterinary Vaccine Revenue Market Share by Application in 2020
Figure 32. China Veterinary Vaccine Sales Growth Rate 2016-2027 (M Doses)
Figure 33. China Veterinary Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Veterinary Vaccine Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Veterinary Vaccine Players Market Share by Revenue in Veterinary Vaccine in 2020
Figure 36. China Veterinary Vaccine Revenue Share by Type (2016-2021)
Figure 37. China Veterinary Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China Veterinary Vaccine Revenue Share by Application (2016-2021)
Figure 39. China Veterinary Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Veterinary Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 41. North America Veterinary Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Veterinary Vaccine Sales Market Share by Country in 2020
Figure 43. North America Veterinary Vaccine Revenue Market Share by Country in 2020
Figure 44. U.S. Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 45. U.S. Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 47. Canada Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Veterinary Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 49. Europe Veterinary Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Veterinary Vaccine Sales Market Share by Country in 2020
Figure 51. Europe Veterinary Vaccine Revenue Market Share by Country in 2020
Figure 52. Germany Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 53. Germany Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 55. France Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 57. U.K. Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 59. Italy Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 61. Russia Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Greece Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 63. Greece Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Ukraine Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 65. Ukraine Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Moldova Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 67. Moldova Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Albania Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 69. Albania Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Serbia Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 71. Serbia Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Asia Pacific Veterinary Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 73. Asia Pacific Veterinary Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 74. Asia Pacific Veterinary Vaccine Sales Market Share by Region in 2020
Figure 75. Asia Pacific Veterinary Vaccine Revenue Market Share by Region in 2020
Figure 76. China Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 77. China Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Japan Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 79. Japan Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. South Korea Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 81. South Korea Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. India Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 83. India Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Australia Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 85. Australia Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Taiwan Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 87. Taiwan Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 88. Indonesia Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 89. Indonesia Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Thailand Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 91. Thailand Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Malaysia Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 93. Malaysia Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Philippines Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 95. Philippines Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Vietnam Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 97. Vietnam Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 98. Latin America Veterinary Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 99. Latin America Veterinary Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 100. Latin America Veterinary Vaccine Sales Market Share by Country in 2020
Figure 101. Latin America Veterinary Vaccine Revenue Market Share by Country in 2020
Figure 102. Mexico Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 103. Mexico Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Brazil Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 105. Brazil Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Argentina Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 107. Argentina Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 108. Middle East and Africa Veterinary Vaccine Sales Growth Rate 2016-2021 (M Doses)
Figure 109. Middle East and Africa Veterinary Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 110. Middle East and Africa Veterinary Vaccine Sales Market Share by Country in 2020
Figure 111. Middle East and Africa Veterinary Vaccine Revenue Market Share by Country in 2020
Figure 112. Turkey Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 113. Turkey Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 114. Saudi Arabia Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 115. Saudi Arabia Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 116. U.A.E Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 117. U.A.E Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 118. Egypt Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 119. Egypt Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 120. South Africa Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 121. South Africa Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 122. Israel Veterinary Vaccine Sales Growth Rate (2016-2021) (M Doses)
Figure 123. Israel Veterinary Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 124. Veterinary Vaccine Value Chain
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
獣医用ワクチンの世界市場 2020年 Market Overview The Veterinary Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…- 世界の豚丹毒ワクチン市場インサイト・予測（～2027年） Swine Erysipelas Vaccine is used to prevent swine erysipelas. For pigs after weaning, the immunization period is 6 months. Market Analysis and Insights: Global Swine Erysipelas Vaccine Market The global Swine Erysipelas Vaccine market is valued at US$ XX million in 2020. The market size will reach U…
- 世界の豚丹毒ワクチン市場インサイト・予測（～2027年） Swine Erysipelas Vaccine is used to prevent swine erysipelas. For pigs after weaning, the immunization period is 6 months. Market Analysis and Insights: Global Swine Erysipelas Vaccine Market The global Swine Erysipelas Vaccine market is valued at US$ XX million in 2020. The market size will reach U…
- 豚生殖・呼吸器症候群ワクチンの世界及び中国市場 Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Boehringer ingelheim is the company with the largest market share, about 25 percent. Market Analysis and Insights: Global a…
- 魚ワクチンの世界及び中国市場 Fish vaccine are vaccine specially used on fish. The culture environment, be it in tanks, cages or ponds, seawater or freshwater, can stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed an…